Published in Cancer Cell on July 11, 2016
Impact of Dietary Intervention on Tumor Immunity: the DigesT Trial (DIgesT) | NCT03454282
Molecular Pathways Related to Short-term Fasting Response | NCT04259879
Activating autophagy to potentiate immunogenic chemotherapy and radiation therapy. Nat Rev Clin Oncol (2016) 0.88
Targeting Cancer Metabolism: Dietary and Pharmacologic Interventions. Cancer Discov (2016) 0.82
Considerations for successful cancer immunotherapy in aged hosts. Clin Exp Immunol (2016) 0.81
Commentary: Fasting-Mimicking Diet Reduces HO-1 to Promote T Cell-Mediated Tumor Cytotoxicity. Front Oncol (2017) 0.78
HO-1 Induction in Cancer Progression: A Matter of Cell Adaptation. Antioxidants (Basel) (2017) 0.76
Fasting regulates EGR1 and protects from glucose- and dexamethasone-dependent sensitization to chemotherapy. PLoS Biol (2017) 0.75
Autophagy-dependent danger signaling and adaptive immunity to poorly immunogenic tumors. Oncotarget (2016) 0.75
Starving leukemia to induce differentiation. Nat Med (2017) 0.75
Chemotherapy: Putting tumours on a diet. Nat Rev Cancer (2016) 0.75
Fasting improves anticancer immunosurveillance via autophagy induction in malignant cells. Cell Cycle (2016) 0.75
Hunger Pains: Stimulating the Appetite of the Immune System for Cancer. Cancer Cell (2016) 0.75
Differentiation impairs Bach1 dependent HO-1 activation and increases sensitivity to oxidative stress in SH-SY5Y neuroblastoma cells. Sci Rep (2017) 0.75
Anticancer effects of the microbiome and its products. Nat Rev Microbiol (2017) 0.75
Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A (2005) 167.46
Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A (2001) 132.88
Nivolumab plus ipilimumab in advanced melanoma. N Engl J Med (2013) 17.53
PAGE: parametric analysis of gene set enrichment. BMC Bioinformatics (2005) 8.41
Chimeric antigen receptor T cells for sustained remissions in leukemia. N Engl J Med (2014) 8.21
Natural innate and adaptive immunity to cancer. Annu Rev Immunol (2011) 7.09
Analysis of microarray data using Z score transformation. J Mol Diagn (2003) 6.82
Immunological aspects of cancer chemotherapy. Nat Rev Immunol (2008) 6.61
Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med (2000) 6.32
Cancer despite immunosurveillance: immunoselection and immunosubversion. Nat Rev Immunol (2006) 6.13
Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice. Science (2011) 5.62
Pharmacological and clinical aspects of heme oxygenase. Pharmacol Rev (2008) 5.34
Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications. FASEB J (1988) 5.24
Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death. J Exp Med (2005) 4.32
Efficacy of low-dose methotrexate in rheumatoid arthritis. N Engl J Med (1985) 3.37
Starvation-dependent differential stress resistance protects normal but not cancer cells against high-dose chemotherapy. Proc Natl Acad Sci U S A (2008) 3.30
Cross-presentation: underlying mechanisms and role in immune surveillance. Immunol Rev (2005) 2.98
Fasting cycles retard growth of tumors and sensitize a range of cancer cell types to chemotherapy. Sci Transl Med (2012) 2.58
Prolonged fasting reduces IGF-1/PKA to promote hematopoietic-stem-cell-based regeneration and reverse immunosuppression. Cell Stem Cell (2014) 2.24
The CO/HO system reverses inhibition of mitochondrial biogenesis and prevents murine doxorubicin cardiomyopathy. J Clin Invest (2007) 1.98
Allogeneic IgG combined with dendritic cell stimuli induce antitumour T-cell immunity. Nature (2015) 1.87
Molecular pathways: involvement of immune pathways in the therapeutic response and outcome in breast cancer. Clin Cancer Res (2012) 1.77
Fasting and cancer treatment in humans: A case series report. Aging (Albany NY) (2009) 1.71
Reduced levels of IGF-I mediate differential protection of normal and cancer cells in response to fasting and improve chemotherapeutic index. Cancer Res (2010) 1.69
Immune-based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale-based combined treatments against cancer. Cell Death Differ (2013) 1.60
Short-term calorie and protein restriction provide partial protection from chemotoxicity but do not delay glioma progression. Exp Gerontol (2013) 1.57
Carbon monoxide inhibits sprouting angiogenesis and vascular endothelial growth factor receptor-2 phosphorylation. Thromb Haemost (2014) 1.48
A Periodic Diet that Mimics Fasting Promotes Multi-System Regeneration, Enhanced Cognitive Performance, and Healthspan. Cell Metab (2015) 1.48
Doxorubicin eliminates myeloid-derived suppressor cells and enhances the efficacy of adoptive T-cell transfer in breast cancer. Cancer Res (2013) 1.42
CD4+ CD25+ FoxP3+ T-cell infiltration and heme oxygenase-1 expression correlate with tumor grade in human gliomas. J Neurooncol (2007) 1.35
Prospective validation of immunological infiltrate for prediction of response to neoadjuvant chemotherapy in HER2-negative breast cancer--a substudy of the neoadjuvant GeparQuinto trial. PLoS One (2013) 1.34
Immunology beats cancer: a blueprint for successful translation. Nat Immunol (2012) 1.32
Upregulation of heme oxygenase-1 and p21 confers resistance to apoptosis in human gastric cancer cells. Oncogene (2004) 1.26
Critical role of heme oxygenase-1 in Foxp3-mediated immune suppression. Biochem Biophys Res Commun (2005) 1.22
Inhibition of heme oxygenase-1 by zinc protoporphyrin IX reduces tumor growth of LL/2 lung cancer in C57BL mice. Int J Cancer (2007) 1.19
An integral role for heme oxygenase-1 and carbon monoxide in maintaining peripheral tolerance by CD4+CD25+ regulatory T cells. J Immunol (2005) 1.16
Chemotherapy-induced immunosuppression. Environ Health Perspect (1982) 1.13
Carbon monoxide expedites metabolic exhaustion to inhibit tumor growth. Cancer Res (2013) 1.12
Cyclophosphamide suppression of established cell-mediated immunity. Quantitative vs. qualitative changes in lymphocyte populations. J Clin Invest (1975) 1.09
A high molecular weight melanoma-associated antigen-specific chimeric antigen receptor redirects lymphocytes to target human melanomas. Cancer Res (2010) 1.02
Treatment of multiple sclerosis with cyclophosphamide: critical review of clinical and immunologic effects. Mult Scler (2002) 1.01
Heme oxygenase-1 protects against apoptosis induced by tumor necrosis factor-alpha and cycloheximide in papillary thyroid carcinoma cells. J Cell Biochem (2004) 0.94
Zinc protoporphyrin IX stimulates tumor immunity by disrupting the immunosuppressive enzyme indoleamine 2,3-dioxygenase. Mol Cancer Ther (2010) 0.94
The role of heme oxygenase-1 in T cell-mediated immunity: the all encompassing enzyme. Curr Pharm Des (2008) 0.89
Increased primary cell-mediated immunity in culture subsequent to adriamycin or daunorubicin treatment of spleen donor mice. Cancer Res (1977) 0.88
Nrf2-heme oxygenase-1 axis in mucoepidermoid carcinoma of the lung: Antitumoral effects associated with down-regulation of matrix metalloproteinases. Free Radic Biol Med (2015) 0.88
Signal peptide peptidase-mediated nuclear localization of heme oxygenase-1 promotes cancer cell proliferation and invasion independent of its enzymatic activity. Oncogene (2014) 0.85
Doxorubicin treatment induces tumor cell death followed by immunomodulation in a murine neuroblastoma model. Exp Ther Med (2014) 0.84
Inhibition of heme oxygenase-1 enhances anti-cancer effects of arsenic trioxide on glioma cells. J Neurooncol (2011) 0.83
Augmentation of the generation of cell-mediated cytotoxicity after a single dose of adriamycin in cancer patients. Cancer Res (1986) 0.83
Commentary: Fasting-Mimicking Diet Reduces HO-1 to Promote T Cell-Mediated Tumor Cytotoxicity. Front Oncol (2017) 0.78